A phase 2 study of Bortezomib in relapsed, refractory myeloma

Paul G. Richardson, Bart Barlogie, James Berenson, Seema Singhal, Sundar Jagannath, David Irwin, S. Vincent Rajkumar, Gordan Srkalovic, Melissa Alsina, Raymond Alexanian, David Siegel, Robert Z. Orlowski, David Kuter, Steven A. Limentani, Stephanie Lee, Teru Hideshima, Dixie Lee Esseltine, Michael Kauffman, Julian Adams, David P. SchenkeinKenneth C. Anderson

Research output: Contribution to journalArticlepeer-review

2331 Scopus citations

Fingerprint

Dive into the research topics of 'A phase 2 study of Bortezomib in relapsed, refractory myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences